• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

SACLAC

CAS No. 2248703-42-4

SACLAC ( —— )

产品货号. M37347 CAS No. 2248703-42-4

SACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥1397 有现货
10MG ¥1881 有现货
25MG ¥3274 有现货
50MG ¥4622 有现货
100MG ¥6192 有现货
200MG ¥8343 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    SACLAC
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    SACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.
  • 产品描述
    SACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.
  • 体外实验
    ——
  • 体内实验
    ——
  • 同义词
    ——
  • 通路
    Apoptosis
  • 靶点
    Apoptosis
  • 受体
    Apoptosis | Caspase
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    2248703-42-4
  • 分子量
    377.99
  • 分子式
    C20H40ClNO3
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    [C@H]([C@@H](CCCCCCCCCCCCCCC)O)(NC(CCl)=O)CO
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

产品手册
关联产品
  • Azadirachtin

    印楝素具有抗真菌活性,用作杀虫剂。

  • Complanatoside

    沙苑苷是中药沙苑子中发现的黄酮类化合物。

  • Methyl-4-oxoretinoat...

    Methyl-4-oxoretinoate is a synthetic retinoid compound with anticancer compounds that can induce differentiation and apoptosis in cancer cells.Methyl-4-oxoretinoate is used in the treatment of acne, psoriasis, and other skin disorders.Methyl-4-oxoretinoate has the potential to be used in the treatment of a variety of ocular disorders such as age-related macular degeneration. related macular degeneration).